The Current Ratio as of September 2024 (TTM) for ASLAN Pharmaceuticals Limited (ASLN) is 1.05

According to ASLAN Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.05. This represents a change of -42.19% compared to the average of 1.82 of the last 4 quarters.

ASLAN Pharmaceuticals Limited (ASLN) Historical Current Ratio (quarterly & annually)

How has ASLN Current Ratio performed in the past?

The mean historical Current Ratio of ASLAN Pharmaceuticals Limited over the last ten years is 6.79. The current 1.05 Current Ratio has changed 1.45% with respect to the historical average. Over the past ten years (40 quarters), ASLN's Current Ratio was at its highest in in the June 2016 quarter at 63.69. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

ASLAN Pharmaceuticals Limited (ASLN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ASLAN Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ASLAN Pharmaceuticals Limited (ASLN) Average Current Ratio

How has ASLN Current Ratio performed in the past?

The current Current Ratio of ASLAN Pharmaceuticals Limited (ASLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ASLAN Pharmaceuticals Limited (ASLN) Current Ratio vs. Peers

How is ASLN’s Current Ratio compared to its peers?

ASLAN Pharmaceuticals Limited’s Current Ratio is less than Monte Rosa Therapeutics, Inc. (6.56), less than NewAmsterdam Pharma Company N.V. (9.83), greater than Inventiva S.A. (0.95), less than Cullinan Oncology, Inc. (28.87), less than Compass Therapeutics, Inc. (40.74), less than Structure Therapeutics Inc. (41.38), less than IO Biotech, Inc. (7.84), less than Erasca, Inc. (16.79), less than Lyra Therapeutics, Inc. (3.60), less than Anebulo Pharmaceuticals, Inc. (5.32), less than Mineralys Therapeutics, Inc. (11.20), less than AN2 Therapeutics, Inc. (10.61), less than Aerovate Therapeutics, Inc. (6.51), less than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Agios Pharmaceuticals, Inc. (10.09), less than Assembly Biosciences, Inc. (2.74), less than Achilles Therapeutics plc (8.24), greater than CytomX Therapeutics, Inc. (1.00), less than Instil Bio, Inc. (15.06), less than Neoleukin Therapeutics, Inc. (15.33),

Build a custom stock screener for ASLAN Pharmaceuticals Limited (ASLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ASLAN Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ASLAN Pharmaceuticals Limited (ASLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ASLAN Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.